RESEARCH
[Publication] Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-GalCer Derivatives Demonstrating High Binding Affinity to the Lipid Antigen Presenting Molecule CD1d
March 10, 2025

Graphical Abstract
Title | Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-GalCer Derivatives Demonstrating High Binding Affinity to the Lipid Antigen Presenting Molecule CD1d |
---|---|
Authors | Kodai Sueyoshi [1],[2]; Junichiro Kishi [1]; Shinsuke Inuki [3]; Takanori Matsumaru [1]; Yukari Fujimoto [1],[2] |
DOI | https://doi.org/10.1002/chem.202403871 |
Journal | Chemistry |
Vol/Num/Page | 2025 Jan 27; 31(6):e20243871 |
Publication Date | Published online: 2025 Jan 5. |
Affiliations:
[1] Graduate School of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama, Kanagawa, 223-8522, Japan.
[2] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
[3] Graduate School of Biomedical Sciences, Tokushima University, 1-78-1, Shoumachi, Tokushima, Tokushima, 770-8505, Japan.
More Bio2Q News
Open Call: Postdoctoral Fellow for Professor Daniel R. Mende’s Lab
Prof. Daniel R. Mende, specializing in computational biology, microbiome research, metagenomics, pangenomics, AI/ML, and multi-omics data an...
Open Call: Postdoctoral Fellow for Professor Nadinath Nillegoda’s Lab
Prof. Nadinath Nillegoda, specializing in proteostasis and cell repair, is currently hiring a postdoctoral fellow. We are looking for appli...
WPI-Bio2Q Social Event (2025.9.29)
WPI-Bio2Q held a social event at Keio University's Shinanomachi Campus. Date & Time: Monday, September 29, 2025 Venue: Bio2Q Open La...
【Event】Keio Alumni Association Convention 2025
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will give a presentation at the Keio Alumni Association Convent...
Visit to Bio2Q by Dr. Hitoshi Nakagama, President of the Japan Agency for Medica...
On September 22, 2025, Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED), visited Bio2Q. Admi...